Editorial Advisory Board



Winston Wong, PharmD
President, W-Squared Group
Longboat Key, FL


Editorial Advisory Board


Alan Balch, PhD
Chief Executive Officer
Patient Advocacy Foundation
Hampton, VA

Brian Bastean, PharmD, MBA
Founder and Principal
Value-Based Outcomes Evidence
New Hope, PA

Alex W Bastian, MBA
Vice President, GfK Market Access
Strategic Advisor, ASCO Value In Cancer Task Force
San Francisco, CA

Aymen Elfiky, MD, MPH, MSc
Attending Physician, Medical Oncology
Dana Farber Cancer Institute; Brigham and Women’s Hospital 
Harvard Medical School
Boston, MA

Bruce A Feinberg, DO
Vice President of Clinical Affairs
Chief Medical Officer
Cardinal Health Specialty Solutions
Dublin, OH

Dwight Heron, MD, FACRO, FACR
Vice Chairman of Clinical Affairs, UPMC
Medical Director, Via Oncology
Pittsburgh, PA

David Hughes, BSN
Associate Director, Clinical Pathways
Seattle Cancer Care Alliance
Seattle, WA

Edward Li, PharmD, MPH, BCOP
Associate Professor, Pharmacy Practice
University of New England College of Pharmacy
Portland, ME

Eric M Maiese, PhD, MHS
Director, Oncology
Health Economics and Outcomes Research
Janssen Scientific Affairs
Horsham, PA

Gary Owens, MD
Gary Owens Associates
Glen Mills, PA

Patti Peeples, RPH, PhD
CEO, HealthEconomics.com
Principle Researcher, HE Institute
Ponte Vedra Beach, FL

Margaret B Rausa, PharmD
Vice President, Medical Oncology
and Specialty Drug Management
eviCore Healthcare
Bluffton, SC

Amy Schroeder, RPh
Senior Consultant
DK Pierce & Associates
Charlotte, NC

Edward Stepanski, PhD
Chief Operating Officer
Vector Oncology
Professor of Internal Medicine
College of Medicine
University of Tennessee Health Sciences Center
Memphis, TN

Robin T Zon, MD, FACP, FASCO
Chair, ASCO Clinical Pathways Task Force
Medical Oncologist and Partner
Michiana Hematology Oncology
Mishawaka, IN

Gordon Kuntz
Partner, Kuntz Consulting
St Paul, MN